Identification of clinically actionable pharmacogenetic variants during tumor genetic profiling in pediatric cancer patients

被引：2
|
作者：
Hertz, Daniel Louis
Robinson, Dan R.
Lonigro, Robert J.
Wu, Yi-Mi
Vats, Pankaj
Cao, Xuhong
Nobani, Andrew
Mora, Erika
Chinnaiyan, Arul M.
Mody, Rajen
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigain Hlth Syst, Ann Arbor, MI USA
[3] Univ Michigan, Ctr Translat Pathol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.1583
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1583
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pharmacogenetic Review: Germline Genetic Variants Possessing Increased Cancer Risk With Clinically Actionable Therapeutic Relationships
    Saugstad, Austin A.
    Petry, Natasha
    Hajek, Catherine
    FRONTIERS IN GENETICS, 2022, 13
  • [2] Identification of clinically actionable genomic alterations in the tumor and circulation of pancreatic cancer patients
    Sausen, Mark
    Phallen, Jillian
    Adleff, Vilmos
    Jones, Sian
    Leary, Rebecca J.
    Lytle, Karli
    Parpart-Li, Sonya
    Murphy, Derek
    Barrett, Michael T.
    Linehan, David C.
    Maitra, Anirban
    Hruban, Ralph
    Von Hoff, Daniel D.
    Johansen, Julia S.
    Diaz, Luis A.
    Drebin, Jeffrey A.
    Velculescu, Victor E.
    CANCER RESEARCH, 2015, 75
  • [3] Classification of clinically actionable genetic mutations in cancer patients
    Shahzad, Muhammad
    Rafi, Muhammad
    Alhalabi, Wadee
    Ali, Naz Minaz
    Anwar, Muhammad Shahid
    Jamal, Sara
    Ali, Muskan Barket
    Alqurashi, Fahad Abdullah
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 10
  • [4] Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows
    Sobahy, Turki M.
    Tashkandi, Ghassan
    Bahussain, Donya
    Al-Harbi, Raneem
    BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [5] A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations
    George, Sally L.
    Izquierdo, Elisa
    Campbell, James
    Koutroumanidou, Eleni
    Proszek, Paula
    Jamal, Sabri
    Hughes, Deborah
    Yuan, Lina
    Marshall, Lynley V.
    Carceller, Fernando
    Chisholm, Julia C.
    Vaidya, Sucheta
    Mandeville, Henry
    Angelini, Paola
    Wasti, Ajla
    Bexelius, Tomas
    Thway, Khin
    Gatz, Susanne A.
    Clarke, Matthew
    Al-Lazikani, Bissan
    Barone, Giuseppe
    Anderson, John
    Tweddle, Deborah A.
    Gonzalez, David
    Walker, Brian A.
    Barton, Jack
    Depani, Sarita
    Eze, Jessica
    Ahmed, Saira W.
    Moreno, Lucas
    Pearson, Andrew
    Shipley, Janet
    Jones, Chris
    Hargrave, Darren
    Jacques, Thomas S.
    Hubank, Michael
    Chesler, Louis
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 224 - 235
  • [6] Clinically actionable cancer somatic variants (CACSV): a tumor interpreted dataset for analytical workflows
    Turki M. Sobahy
    Ghassan Tashkandi
    Donya Bahussain
    Raneem Al-Harbi
    BMC Medical Genomics, 15
  • [7] Challenges of Identifying Clinically Actionable Genetic Variants for Precision Medicine
    Carter, Tonia C.
    He, Max M.
    JOURNAL OF HEALTHCARE ENGINEERING, 2016, 2016
  • [8] Performance of next-generation sequencing for detection of clinically actionable genetic variants in cancer.
    Hussaini, Mohammed Omar
    Hagemann, Ian S.
    Cox, Teresa Mary
    Lockwood, Christina
    Seibert, Karen
    Kulkarni, Shashikant
    Pfeifer, John
    Duncavage, Eric James
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] Targeted tumor profiling and actionable somatic variants in sarcoma.
    Ben Ami, Eytan
    Hemming, Matthew Louis
    Nathenson, Michael
    Thornton, Katherine Anne
    Merriam, Priscilla
    Morgan, Jeffrey A.
    Raut, Chandrajit P.
    George, Suzanne
    Wagner, Andrew J.
    Demetri, George D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Evaluation of a Screening Tool to Detect Clinically Actionable DNA Variants in Lung Cancer Patients
    Mularo, F.
    Brock, J. E.
    Liyanage, H.
    Shell, S.
    Farkas, D. H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1190 - 1190
12345